The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease
Abstract
Subacute sclerosing panencephalitis (SSPE) is a progressive neurodegenerative disease which affects children and young adults, caused by a persistent infection of defective measles virus. IFN-λs (IL-28A, IL-28B and IL-29) are a group of cytokines mediating antiviral responses. It has been shown that IL-29 levels are significantly higher in infected cells with defective measles virus. IL-29 expression is thought to be regulated at post-transcriptional level and miRNA-548 family targets the 3'UTR of the IFNL1 gene. Impaired immune system has an important role as well as viral factors in SSPE. The aim of our study investigates whether IL-28B, IL-29 levels and gene polymorphisms contribute to the damaged immune response leading to the development of SSPE. Also possible association of miR-548 family with IL-29 and SSPE is explored. Frequencies of rs12979860, rs8099917, rs30461, serum levels of IL-28B, IL-29 and expression levels of miR-548b, miR-548c, miR-548i are determined at 64 SSPE patients and 68 healthy controls. Serum IL-29 levels are statistically significant higher in SSPE patients. Allele frequencies of rs8099917 are statistically significant higher in SSPE patients and resulted G allele is found to increase 2.183-fold risk of SSPE. The expression levels of miR-548b-5p, miR-548c-5p and miR-548i are found to be statistically significant higher in SSPE patients. Dramatically increased level of IL-29 seen in patient group indicates that the elevated miR-548 expression is co…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, hsa-mir-548 family members have been detected from other body fluids in addition to FF: hsa-miR-548b-5p, hsa-miR-548c-5p and hsa-miR-548i [57], and hsa-miR-548a-3p [58] in blood serum samples, hsa-miR-548b-3p in blood plasma, bronchial lavage and peritoneal fluid, and hsa-miR-548d-5p in amniotic fluid [59].”
From Hsa-mir-548 family expression in human reproductive tissues (2021) · cites this paper as [57]
Citations
Cites
MicroRNA expression and function in cancer
Garzon, R., Fabbri, M., Cimmino, A., Calin, G. A., & Croce, C. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.006 · Cited by 780
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Dai, R., & Ahmed, S. A. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.007 · Cited by 444
Interferon-Lambda: A New Addition to an Old Family
Donnelly, R. P., & Kotenko, S. V. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0078 · Cited by 420
Subacute sclerosing panencephalitis
Garg, R. K. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.916.63 · Cited by 401
Honda, M., Sakai, A., Yamashita, T., Nakamoto, Y., Mizukoshi, E., Sakai, Y., Yamashita, T., Nakamura, M., Shirasaki, T., Horimoto, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.049 · Cited by 400
Urban, T. J., Thompson, A. J., Bradrick, S. S., Fellay, J., Schuppan, D., Cronin, K. D., Hong, L., McKenzie, A., Patel, K., Shianna, K. V., et al. (2010) · Hepatology · doi:10.1002/hep.23912 · Cited by 361
MicroRNAs and Immunity: Tiny Players in a Big Field
Taganov, K. D., Boldin, M. P., & Baltimore, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.005 · Cited by 343
MicroRNA turnover: when, how, and why
Rüegger, S., & Großhans, H. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.07.002 · Cited by 271
Akuta, N., Suzuki, F., Hirakawa, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Suzuki, Y., Hosaka, T., Kobayashi, M., Kobayashi, M., et al. (2010) · Hepatology · doi:10.1002/hep.23690 · Cited by 256
Subacute sclerosing panencephalitis: an update
GUTIERREZ, J., ISSACSON, R. S., & KOPPEL, B. S. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03717.x · Cited by 230
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2005 · Cited by 205
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
Bibert, S., Roger, T., Calandra, T., Bochud, M., Cerny, A., Semmo, N., Duong, F. H. T., Gerlach, T., Malinverni, R., Moradpour, D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130012 · Cited by 201
Human interferon-λ3 is a potent member of the type III interferon family
Dellgren, C., Gad, H. H., Hamming, O. J., Melchjorsen, J., & Hartmann, R. (2009) · Genes & Immunity · doi:10.1038/gene.2008.87 · Cited by 170
Subacute sclerosing panencephalitis
Garg, R. K. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0032-6 · Cited by 162
Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L., & Houghton, M. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.51 · Cited by 160
Interferon Lambda: Modulating Immunity in Infectious Diseases
Syedbasha, M., & Egli, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00119 · Cited by 160
Interferon-lambda serum levels in hepatitis C
Langhans, B., Kupfer, B., Braunschweiger, I., Arndt, S., Schulte, W., Nischalke, H. D., Nattermann, J., Oldenburg, J., Sauerbruch, T., & Spengler, U. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.020 · Cited by 147
Measles virus, immune control, and persistence
Griffin, D. E., Lin, W.-H. W., & Pan, C.-H. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00330.x · Cited by 134
IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway
Zhang, L., Jilg, N., Shao, R., Lin, W., Fusco, D., Zhao, H., Goto, K., Peng, L. F., Chen, W., & Chung, R. T. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.019 · Cited by 130
Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29)
Jordan, W. J., Eskdale, J., Boniotto, M., Rodia, M. T., Kellner, D. B., & Gallagher, G. E. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364348 · Cited by 128
Molecular mechanisms of measles virus persistence
Rima, B. K., & Duprex, W. P. (2005) · Virus Research · doi:10.1016/j.virusres.2005.04.005 · Cited by 117
Chayama, K., Hayes, C. N., Abe, H., Miki, D., Ochi, H., Karino, Y., Toyota, J., Nakamura, Y., Kamatani, N., Sezaki, H., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir210 · Cited by 115
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
Egli, A., Santer, D. M., O’Shea, D., Barakat, K., Syedbasha, M., Vollmer, M., Baluch, A., Bhat, R. K., Groenendyk, J., Joyce, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004556 · Cited by 110
MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1
Li, Y., Xie, J., Xu, X., Wang, J., Ao, F., Wan, Y., & Zhu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2081-y · Cited by 107
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Lange, C. M., & Zeuzem, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.006 · Cited by 102
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
Egli, A., Levin, A., Santer, D. M., Joyce, M., O’Shea, D., Thomas, B., Lisboa, L. F., Barakat, K., Bhat, R. K., Fischer, K. P., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu144 · Cited by 77
Subacute sclerosing panencephalitis
Gascon, G. G. (1996) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(96)80030-1 · Cited by 73
Smith, K. R., Suppiah, V., O'Connor, K. S., Berg, T., Weltman, M., Abate, M. L., Spengler, U., Bassendine, M. F., Matthews, G. V., Irving, W. L., et al. (2011) · Genome Medicine · doi:10.1186/gm273 · Cited by 72
Duong, F. H. T., Trincucci, G., Boldanova, T., Calabrese, D., Campana, B., Krol, I., Durand, S., Heydmann, L., Zeisel, M. B., Baumert, T. F., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131557 · Cited by 65
Dyken, P. R. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1030 · Cited by 64
Hara, T., Yamashita, S., Aiba, H., Nihei, K., Koide, N., Good, R. A., & Takeshita, K. (2000) · Journal of NeuroVirology · doi:10.3109/13550280009013155 · Cited by 55
Expression of cytokines in brain lesions in subacute sclerosing panencephalitis
NAGANO, I., Nakamura, S., Yoshioka, M., Onodera, J., Kogure, K., & Itoyama, Y. (1994) · Neurology · doi:10.1212/wnl.44.4.710 · Cited by 53
Tissue Inflammatory Response in Subacute Sclerosing Panencephalitis (SSPE)
Anlar, B., Söylemezoğlu, F., Aysun, S., Köse, G., Belen, D., & Yalaz, K. (2001) · Journal of Child Neurology · doi:10.1177/088307380101601206 · Cited by 44
Galmozzi, E., Viganò, M., & Lampertico, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12631 · Cited by 43
Understanding the causes and consequences of measles virus persistence
Griffin, D. E., Lin, W.-H. W., & Nelson, A. N. (2018) · F1000Research · doi:10.12688/f1000research.12094.1 · Cited by 25
Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis
Aydın, Ö. F., Ichiyama, T., & Anlar, B. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.04.018 · Cited by 22
Alterations in cell-mediated immune response in subacute sclerosing panencephalitis
Yentur, S. P., Gürses, C., Demirbilek, V., Yılmaz, G., Önal, A. E., Yapıcı, Z., Yalçınkaya, C., Çokar, Ö., Gökyiğit, A., & Saruhan‐Direskeneli, G. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.002 · Cited by 22
Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis
Saruhan‐Direskeneli, G., Gürses, C., Demirbilek, V., Yentur, S. P., Yılmaz, G., Önal, E., Yapıcı, Z., Yalçınkaya, C., Çokar, Ö., Akman‐Demir, G., et al. (2005) · Cytokine · doi:10.1016/j.cyto.2005.08.004 · Cited by 21
Familial subacute sclerosing panencephalitis in two siblings
Tuxhorn, I. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2004.03.015 · Cited by 18
Jin, G., Kang, H., Chen, X., & Dai, D. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.10.009 · Cited by 17
Subacute Sclerosing Panencephalitis of the Brainstem as a Clinical Entity
Upadhyayula, P. S., Yang, J., Yue, J. K., & Ciacci, J. D. (2017) · Medical Sciences · doi:10.3390/medsci5040026 · Cited by 17
Expression Patterns of Micro-RNAs 146a, 181a, and 155 in Subacute Sclerosing Panencephalitis
Yiş, U., Tüfekçi, K. U., Genç, Ş., Çarman, K. B., Bayram, E., Topçu, Y., & Kurul, S. H. (2014) · Journal of Child Neurology · doi:10.1177/0883073814531329 · Cited by 11
Hasegawa, S., Mori, N., Satomi, M., Jiang, D., Hotta, H., Matsushige, T., & Ichiyama, T. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.003 · Cited by 6
IL-28 and IL-29 as protective markers in subject with dengue fever
Hung, C., Huang, C., Wang, L., Huang, C.-C., Wu, M., Chin, Y.-Y., Lin, C., Chang, K., Wu, D., & Chen, Y. (2017) · Medical Microbiology and Immunology · doi:10.1007/s00430-017-0498-x · Cited by 6
Cited by
Hsa-mir-548 family expression in human reproductive tissues
Rooda, I., Kaselt, B., Liivrand, M., Smolander, O.-P., Salumets, A., & Velthut-Meikas, A. (2021) · BMC Genomic Data · doi:10.1186/s12863-021-00997-w · Cited by 17
Metadata
- Authors
- Cakmak Genc, G., Dursun, A., Karakas Celik, S., Calik, M., Kokturk, F., & Piskin, I. E.
- ORCID
- Cakmak Genc, Gunes
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 678
- Pages
- 73-78
- ISSN
- 0378-1119
- Cited by
- 22
- References
- 46
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Bulent Ecevit University, Turkey (2014-93106430-01)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.